文献速递胃肠动力与功能性疾病

食管功能性管腔成像探头引导的幽门扩张改善胃轻瘫症状

Pyloric dilation with the esophageal functional lumen imaging probe in gastroparesis improves gastric emptying, pyloric distensibility, and symptoms.
PubMed 文献 · Gastrointest Endosc · 2021-03-23

本研究评估食管FLIP(EsoFLIP)引导下幽门扩张对胃轻瘫患者胃排空、症状及FLIP指标的影响。

要点

  • EsoFLIP引导幽门扩张可显著缩短胃排空时间。
  • 扩张后幽门扩张性及症状量表评分显著改善。
  • 中位随访3.9个月,57%患者报告症状改善。

核心结论

  • EsoFLIP引导的幽门扩张在胃轻瘫治疗中具有主观和客观价值。

主要发现

  • 幽门扩张性、PAGI-SYM、PAGI-QOL及GCSI评分均显著改善。
  • 中位随访3.9个月,57%返回问卷的患者报告症状改善。

关键数值与推荐

  • 胃轻瘫诊断依据:13C-辛酸呼气试验胃排空t1/2≥180分钟或胃镜下胃残留。
  • 扩张方案依据自行开发的算法进行。

临床怎么用

  • 对于胃轻瘫患者,可考虑EsoFLIP引导幽门扩张以改善胃排空和症状。

局限性

  • 需长期随访评估疗效,并开展对照试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The role of decreased pyloric distensibility in gastroparesis as measured by the endolumenal functional luminal imaging probe (EndoFLIP) has been receiving increasing attention. In this study, we present clinical outcomes to pyloric dilation with the esophageal FLIP (EsoFLIP) in regard to gastric emptying, symptom evolution, and FLIP metrics. METHODS: Patients evaluated for gastroparesis (gastric emptying studies of t1/2 ≥180 minutes during 13C-octanoic acid breath test and/or gastric remnants during gastroscopy after a sufficient fasting period) were scheduled for EsoFLIP controlled pyloric dilation. Pre- and postprocedural gastric emptying studies, questionnaires (Patient Assessment of Upper GI Symptoms Severity Index [PAGI-SYM; including the Gastroparesis Cardinal Symptom Index] and Patient Assessment of Quality of Life Index [PAGI-QOL]), and FLIP metrics were documented. Dilation was conducted according to a self-developed algorithm. RESULTS: Forty-six patients were analyzed (72% women; median age, 39 years [range, 18-88]). Etiologies of gastroparesis were diabetic in 10 patients (22%), idiopathic in 33 (72%), and postoperative in 3 (6%). Postprocedural gastric emptying time decreased from a median of 211 minutes to 179 minutes (P = .001). In accordance, pyloric distensibility, PAGI-SYM, PAGI-QOL, and Gastroparesis Cardinal Symptom Index values improved significantly. After a median follow-up of 3.9 months, 57% of all treated patients with returned questionnaires reported improved symptoms. CONCLUSIONS: Pyloric EsoFLIP controlled dilation shows value in the treatment of gastroparesis, both subjectively and objectively. Long-term follow-up to assess efficacy and comparative trials are warranted.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Murray FR, Schindler V, Hente JM, et al. Pyloric dilation with the esophageal functional lumen imaging probe in gastroparesis improves gastric emptying, pyloric distensibility, and symptoms. Gastrointest Endosc. 2021. PMID: 33771556. doi:10.1016/j.gie.2021.03.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。